Article

jdsupra.com on 2019-01-08 21:24

Looking to 2019 and beyond - accessing the U.S. pharma/biotech market: U.S. drug inspections in China: Staying ahead of FDA enforcement trends

On November 8, a team of life sciences lawyers from our Washington, D.C., New York, and Beijing offices hosted a seminar in Beijing on the key ...

Related news

Looking to 2019 and beyond - accessing the U.S. pharma/biotech market: Considerations for structuring and bridging the valuation gap in life sciences M&A transactions jdsupra.com
California , United States , Switzerland
Looking to 2019 and beyond - accessing the U.S. pharma/biotech market: Preliminary regulatory barriers life sciences acquirers face in China/U.S. cross-border transactions jdsupra.com
California , Switzerland , United States , Taiwan , China
Why Biotech and Pharma Patents Survive IPR jdsupra.com
California , United States , Switzerland
[Event] 11th Pharma & Biotech Patent Litigation - February 26 - 27, 2019 - Radisson Blu Hotel, Amsterdam jdsupra.com
California , United States , Switzerland , Amsterdam
Senate Proposal for Section 101 Reform: Effect on Biotech/Pharma Inventions jdsupra.com
California , United States , Switzerland
Uncharted Waters: Potential Regulatory Impacts of Coronavirus (COVID-19) on Pharma and Biotech Industries jdsupra.com
California , United States , Switzerland
Are you a foreign business interested in accessing the U.S market? Here's what you need to know.jdsupra.com
California , Switzerland , United States
For patients’ sake, U.S. must slap down Big Pharma chiseling on tests, trials jdsupra.com
California , United States , Switzerland
2023 IP Outlook: Patent Decisions Affecting Pharma and Biotech Companies jdsupra.com
Sherman , Baltimore , United States
Staying Aware of U.S. Competition Legal Issues at a Time of Economic Upheaval jdsupra.com
California , United States , Switzerland , Aware
A “Heads Up” for U.S. Employers of STEM Optional Practical Training Workers: ICE Starts Conducting On-Site Inspections for STEM OPT Employment jdsupra.com
California , United States , Switzerland
FDA Releases Policy on Risk-Based Inspections jdsupra.com
California , United States , Switzerland
COVID-19: Staying Engaged, Staying Connected and Staying Calm jdsupra.com
California , United States , Switzerland
China Aims to Introduce Routine Drug and Device Overseas Inspections jdsupra.com
California , United States , Switzerland , China
Pharma Review - Issue 3 jdsupra.com
California , United States , Switzerland
Privacy Tip #154 – Accessing the Do-Not-Call Registry jdsupra.com
California , United States , Switzerland
India’s Pharma Sector Faces Roadblocks in U.S.tntribune.com
Kendal , Americas , Kashmir , Leh , China
Treasury to Extend Deadlines for Accessing Wind, Solar Tax Credits jdsupra.com
California , United States , Switzerland
Considerations in Accessing Revolving Credit Lines jdsupra.com
California , United States , Switzerland
ICE Begins STEM OPT Worksite Inspections jdsupra.com
California , United States , Switzerland